Stereotactic Surgery Devices Market is segmented By Product Type (Gamma Knife, Linear Particle Accelerators, Proton Therapy Systems, Stereotactic Syst....
Market Size in USD
CAGR5.37%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 5.37% |
Market Concentration | High |
Major Players | Elekta AB, Accuray Inc., Ion Beam Application S.A., Mevion Medical Systems, Varian Medical Systems, Inc |
The Global Stereotactic Surgery Devices Market is estimated to be valued at USD 29.1 Bn in 2024 and is expected to reach USD 38.2 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.37% from 2024 to 2031. Stereotactic surgery devices are used in various minimally invasive surgeries of the brain and these devices help in precisely locating tumors and other lesions for effective treatment with procedures like radiosurgery and biopsy.
The stereotactic surgery devices market is expected to witness steady growth owing to the increasing incidence of brain tumors and other neurological disorders globally. As stereotactic surgery offers advantages like minimal invasiveness, reduced recovery time and hospital stay along with better precision, its adoption rate is increasing worldwide. Further technological advancements improving navigational abilities and efficiency are projected to drive the market during the forecast period.